1-4 of 4
Catherine Couturier
Close
Sort by
Journal Articles

Evaluation of Experimental Retreatment and Prolonged Therapy with Subcutaneous (SC) Bortezomib in Patients (Pts) with Multiple Myeloma in First or Second Relapse, a Randomized, Controlled, Phase 3 Study

Michele Cavo, MD, Marco Gobbi, MD, Anna Potamianou, MD PhD, Marjolein Lahaye, MSc, Catherine Couturier, PharmD, Evangelos Terpos, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3328.
https://doi.org/10.1182/blood.V128.22.3328.3328
Published: 2016
Journal Articles

Analysis of Final Data from the Multinational, Non-Interventional, Observational Emmos Study (NCT01241396) in Patients (Pts) with Multiple Myeloma (MM) in Real-World Clinical Practice

Mohamad Mohty, MD PhD, Evangelos Terpos, Maria-Victoria Mateos, Antonio Palumbo, MD, Sandra Lejniece, Meral Beksac, MD, Mohamed Amine Bekadja, Wojciech Legiec, Meletios Dimopoulos, Svetlana Stankovic, PhD, Maria Soledad Durán, Valerio De Stefano, MD, Alessandro Corso, MD, Yulia Kochkareva, Edward Laane, MD PhD, Christian Berthou, MD PhD, Hans-Juergen Salwender, MD, Zvenyslava Masliak, Valdas Pečeliūnas, Wolfgang Willenbacher, MD, João Da Silva, Vernon Louw, Damir Nemet, MD PhD, Zita Borbényi, MD PhD, Uri Abadi, MD, Robert Schou Pedersen, Peter Cernelc, Anna Potamianou, MD PhD, Catherine Couturier, Robert Olie, PhD, Caroline Feys, MSc, MBA, Florence Thoret-Bauchet, Mario Boccadoro, MD
Journal: Blood
Blood (2015) 126 (23): 3034.
https://doi.org/10.1182/blood.V126.23.3034.3034
Published: 2015
Journal Articles

Retrospective Matched-Pair Analysis Of The Efficacy and Safety Of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients (Pts) With Relapsed Multiple Myeloma (MM)

Meletios A. Dimopoulos, MD, Robert Z. Orlowski, M.D., Ph.D, Thierry Facon, MD, Pieter Sonneveld, MD, Ph.D, Kenneth C. Anderson, MD, Meral Beksac, MD, Lotfi Benboubker, MD, Huw Roddie, MBChB, Ph.D, Anna Potamianou, MD, Catherine Couturier, PharmD, Huaibao Feng, Ph.D, Ozlem Ataman, MD, Ph.D, Helgi van de Velde, Paul G. Richardson, MD
Journal: Blood
Blood (2013) 122 (21): 3177.
https://doi.org/10.1182/blood.V122.21.3177.3177
Published: 2013
Journal Articles

Bortezomib-Dexamethasone Alone or Plus Cyclophosphamide or Lenalidomide As Second-Line Treatment for Patients with Multiple Myeloma: Final Results From a Phase 2 Study

Meletios Athanasios Dimopoulos, MD, Meral Beksac, MD, Lotfi Benboubker, MD, PhD, Huw Roddie, MBChB, PhD, Nathalie Allietta, Esther Broer, Catherine Couturier, PharmD, Marie-Andrée Mazier, DESS, Ralf Angermund, MD, Thierry Facon, MD
Journal: Blood
Blood (2011) 118 (21): 1861.
https://doi.org/10.1182/blood.V118.21.1861.1861
Published: 2011